Biopharma Daily Updates - 12/15/20
Dec 15, 2020
1 min read
$XBI $146.32 (+0.2%)
Data Updates:
$ATNX (-6%) - FDA approval of Klisyri (Tirbanibulin)
$KNSA (+0.5%) - Start enrollment in ph2b of Vixarelimab
$NKTR (+4.5%) - Dosing underway in ph1/2 of NKTR-255 + Cetuximab
$GILD (-0.5%) + $GLPG (-1%) - Agreement for Jyseleca (Filgotinib)
$RDUS (+5%) - Tymlos sales update
Financial Updates
$PHAT (+13%) - Public offering
$TGTX (+17%) - Prices offering at $43.50/share
$MIRM (-23%) - Prices offering at $20/share
Comments